Perioperative Multi-Kingdom Gut Microbiota Alters in Coronary Artery Bypass Grafting

Zhou Fu1,2, Yanxiong Jia1,2, Jing Zhao1,2

  • 1Department of Cardiovascular Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.

Biomedicines
|February 26, 2025
PubMed

Insights

Coronary artery bypass grafting (CABG) surgery significantly alters the gut microbiome, reducing beneficial bacteria and increasing harmful microbes. These shifts in multi-kingdom gut microbiota impact patient health and postoperative recovery.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Cardiovascular Surgery

Background:

  • Coronary artery bypass grafting (CABG) is a primary treatment for coronary heart disease (CHD).
  • Gut microbiota alterations have been linked to CHD, but post-CABG changes across multiple microbial kingdoms remain unclear.

Purpose of the Study:

  • To investigate the dynamic changes in the multi-kingdom gut microbiota composition and function during the early postoperative period following CABG.

Main Methods:

  • Fecal samples were collected from 40 patients before and one week after CABG.
  • Metagenomic sequencing was employed to analyze the microbial spectrum and functional genes within the fecal samples.

Main Results:

  • Significant shifts in multi-kingdom gut microbiota and gene functions were observed post-CABG.
  • Beneficial bacteria (e.g., Bifidobacterium, Bacteroides) decreased, while harmful bacteria (e.g., Enterococcus) increased.
  • Fungal and archaeal populations changed, with specific increases in Saccharomyces cerevisiae and decreases in Methanomethylovorans-SGB40959.
  • A significant increase in Enterococcus virus EFP01 was noted, correlating with Enterococcus abundance.
  • Postoperative dysregulation of gene functions, including the Phosphoenolpyruvate-dependent Sugar Phosphotransferase System (PTS), was identified.

Conclusions:

  • CABG surgery induces substantial alterations in the gut microbiota across bacteria, fungi, archaea, and viruses.
  • The observed reduction in beneficial microbes and increase in pathogenic ones highlight potential clinical implications for post-CABG patient health.
  • Modulating gut microbiota may offer future therapeutic strategies to improve outcomes for CABG patients.